Adipocyte-Specific ACKR3 Regulates Lipid Levels in Adipose Tissue

Selin Gencer, Yvonne Doering, Yvonne Jansen, Soyolmaa Bayasgalan, Olga Schengel, Madeleine Mueller, Linsey J. F. Peters, Christian Weber, Emiel P. C. van der Vorst*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Dysfunctional adipose tissue (AT) may contribute to the pathology of several metabolic diseases through altered lipid metabolism, insulin resistance, and inflammation. Atypical chemokine receptor 3 (ACKR3) expression was shown to increase in AT during obesity, and its ubiquitous elimination caused hyperlipidemia in mice. Although these findings point towards a role of ACKR3 in the regulation of lipid levels, the role of adipocyte-specific ACKR3 has not yet been studied exclusively in this context. In this study, we established adipocyte- and hepatocyte-specific knockouts of Ackr3 in ApoE-deficient mice in order to determine its impact on lipid levels under hyperlipidemic conditions. We show for the first time that adipocyte-specific deletion of Ackr3 results in reduced AT triglyceride and cholesterol content in ApoE-deficient mice, which coincides with increased peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and increased Angptl4 expression. The role of adipocyte ACKR3 in lipid handling seems to be tissue-specific as hepatocyte ACKR3 deficiency did not demonstrate comparable effects. In summary, adipocyte-specific ACKR3 seems to regulate AT lipid levels in hyperlipidemic Apoe(-/-) mice, which may therefore be a significant determinant of AT health. Further studies are needed to explore the potential systemic or metabolic effects that adipocyte ACKR3 might have in associated disease models.

Original languageEnglish
Article number394
Number of pages11
Issue number4
Publication statusPublished - Apr 2021


  • ACKR3
  • adipocyte
  • adipose tissue
  • lipid
  • metabolism
  • hyperlipidemia
  • PPAR-gamma

Cite this